Aetna Transcervical Balloon Tuboplasty Form

Effective Date

08/27/1999

Last Reviewed

05/30/2023

Original Document

  Reference



Background for this Policy

Balloon tuboplasty, one component of a selective salpingography procedure in which flushing with contrast media, wire cannulation or balloon tuboplasty can be used to relieve tubal obstruction, is safe and effective for patients with proximal tubal occlusion as demonstrated on hysterosalpingogram.

Fluoroscopic tubal catheterization (selective salpingography) using an angiographic catheter has been investigated both as a diagnostic technique modality and as a therapeutic modality. With selective salpingography, dye can be injected into the tubes more directly; occasionally this procedure is all that is needed to open the previously occluded fallopian tube. If this does not work, gentle manipulation with a wire is sometimes successful. Finally tubal balloon catheterization (TBT) has been investigated. Therefore, TBT is just one of several manipulations that can be performed at the time of a selective salpingography.

Alternative radiologic methods of clearing tubal obstruction include fallopian tube recanalization by guidewire (NICE, 2004). Tubal obstruction may also be treated surgically.

Scope of Policy

This Clinical Policy Bulletin addresses transcervical balloon tuboplasty.

Medical Necessity

Aetna considers transcervical balloon tuboplasty medically necessary for members with infertility due to a proximal tubal occlusion demonstrated on hysterosalpingogram.

Experimental and Investigational

Transcervical balloon tuboplasty is considered experimental and investigational for all other indications because its effectiveness for indications other than the one listed above has not been established.